Altium Capital Management LP Verrica Pharmaceuticals Inc. Transaction History

Altium Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.81 - $8.93 $177,175 - $874,130	-97,887 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$9.1 - $13.36 $1.44 Million - $2.12 Million	-158,357 Reduced 61.8%	97,887 $897,000
Q3 2021 Nov 15, 2021	SELL	$9.55 - $13.96 $2.57 Million - $3.75 Million	-268,883 Reduced 51.2%	256,244 $3.29 Million
Q2 2021 Aug 13, 2021	SELL	$9.77 - $15.33 $369,569 - $579,887	-37,827 Reduced 6.72%	525,127 $5.93 Million
Q1 2021 May 06, 2021	BUY	$10.51 - $17.46 $4.77 Million - $7.93 Million	454,160 Added 417.45%	562,954 $8.53 Million
Q4 2020 Feb 16, 2021	BUY	$7.41 - $12.63 $806,163 - $1.37 Million	108,794 New	108,794 $1.25 Million

17.4M

6.1K

6.3K

Ticker VRCA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,094,100
Market Cap $327M
Description
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...

Get notified when there are updates to the investment portfolio of Altium Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Altium Capital Management LP with notifications on news.